tadalafil (IBSA Institut Biochimique Switzerland)

N/A

Report date: 2025/12/09 17:56:39

Base Information

Drug Nametadalafil (IBSA Institut Biochimique Switzerland)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIbsa Institut Biochimique Sa
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A